Skip to content

Midiclinic

Active
Private limited companyfounded 201115 yrs activeKaudenaardestraat 122, 1700 Dilbeek, BelgiumKBO/BCE: BE 0838.529.465
Summary

Midiclinic has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-62k) and a net result of €-13k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 22% of 4659 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability63▲+63
Solvency3▲+3
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.46 against 0.07 in 2024; short-term debt: 111% and cash: 10.3% of total assets), and equity is negative.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-21.6%
Return on assets
-4.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €-62k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
29 d late
2023
30 d late
2022
29 d late
2021
30 d late
2020
31 d late
2019
15 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€-62k▼ 25.9%
2024 · €-49k
2018: €38khighest in 8 years 2019: €27k▼ -28.4% vs 2018 2020: €26k▼ -4.1% vs 2019 2021: €26k▼ -0.7% vs 2020 2022: €31k▲ +19.1% vs 2021 2023: €-9k▼ -130% vs 2022 2024: €-49k▼ -444% vs 2023 2025: €-62k▼ -25.9% vs 2024lowest in 8 years
2018 → 2025
Total assets
€288k▲ 92.2%
2024 · €150k
2018: €42k 2019: €27k▼ -35.3% vs 2018 2020: €26k▼ -4.1% vs 2019 2021: €26k● +0.0% vs 2020 2022: €50k▲ +93.0% vs 2021 2023: €22k▼ -55.3% vs 2022lowest in 8 years 2024: €150k▲ +568% vs 2023 2025: €288k▲ +92.2% vs 2024highest in 8 years
2018 → 2025
Net result
€-13k▲ 75.7%
2024 · €-53k
2018: €-29k 2019: €-11k▲ +62.6% vs 2018 2020: €-1k▲ +89.6% vs 2019 2021: €-168▲ +84.8% vs 2020 2022: €5k▲ +3010% vs 2021highest in 8 years 2023: €-40k▼ -910% vs 2022 2024: €-53k▼ -32.9% vs 2023lowest in 8 years 2025: €-13k▲ +75.7% vs 2024
2018 → 2025
Working capital
€-173k▲ 6.2%
2024 · €-184k
2018: €26k 2019: €27k▲ +4.2% vs 2018highest in 8 years 2020: €26k▼ -2.9% vs 2019 2021: €26k▼ -0.7% vs 2020 2022: €22k▼ -12.3% vs 2021 2023: €-16k▼ -173% vs 2022 2024: €-184k▼ -1022% vs 2023lowest in 8 years 2025: €-173k▲ +6.2% vs 2024
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€26k-€31k▲ 19.1%€-9k€-49k▼ 444%€-62k▼ 25.9% 2021: €26k 2022: €31k▲ +19.1% vs 2021highest in 5 years 2023: €-9k▼ -130% vs 2022 2024: €-49k▼ -444% vs 2023 2025: €-62k▼ -25.9% vs 2024lowest in 5 years
Operating result€-149-€5k€-39k€-53k▼ 33.1%€-12k▲ 77.1% 2021: €-149 2022: €5k▲ +3593% vs 2021highest in 5 years 2023: €-39k▼ -860% vs 2022 2024: €-53k▼ -33.1% vs 2023lowest in 5 years 2025: €-12k▲ +77.1% vs 2024
Net result€-168-€5k€-40k€-53k▼ 32.9%€-13k▲ 75.7% 2021: €-168 2022: €5k▲ +3010% vs 2021highest in 5 years 2023: €-40k▼ -910% vs 2022 2024: €-53k▼ -32.9% vs 2023lowest in 5 years 2025: €-13k▲ +75.7% vs 2024
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-60k€-40k€-20k€0Operating result 2021: €-149€-149Net result 2021: €-168€-168Operating result 2022: €5k€5kNet result 2022: €5k€5kOperating result 2023: €-39k€-39kNet result 2023: €-40k€-40kOperating result 2024: €-53k€-53kNet result 2024: €-53k€-53kOperating result 2025: €-12k€-12kNet result 2025: €-13k€-13k20212022202320242025€-60k€-40k€-20k€0Operating result 2023: €-39k€-39kNet result 2023: €-40k€-40kOperating result 2024: €-53k€-53kNet result 2024: €-53k€-53kOperating result 2025: €-12k€-12kNet result 2025: €-13k€-13k202320242025
The operating result stays negative: a loss of €12k in 2025 against €53k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €288k
Fixed assets €141k ▲ 3.6%
Current assets €147k ▲ 970%
Key figures and ratios
2025 value · change against 2024
EBITDA
€18k▲
2024 · €-48k
Cash flow
€18k▲
2024 · €-48k
Solvency
-21.6%▲
2024 · -33.0%
Current ratio
0.46▲
2024 · 0.07
Debt to equity
-5.63▼
2024 · -4.03
ROA
-4.4%▲
2024 · -35.2%
Interest coverage
24.64▲
2024 · -299.24
Debt
€350k▲
2024 · €199k
Debt ≤ 1 year
€319k▲
2024 · €198k
Staff costs
€91k▲
2024 · €39k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€150k€288k▲
Fixed assets21/28€136k€141k▲
Intangible fixed assets21€3k€8k▲
Tangible fixed assets22/27€128k€127k▼
Plant, machinery and equipment23€125k€123k▼
Furniture and vehicles24€3k€4k▲
Financial fixed assets28€5k€5k=
Current assets29/58€14k€147k▲
Amounts receivable within one year40/41€3k€105k▲
Trade receivables40-€100k
Other amounts receivable41€3k€5k▲
Cash at bank and in hand54/58€6k€30k▲
Deferred charges and accrued income490/1€5k€12k▲
Equity and liabilities
Total equity and liabilities10/49€150k€288k▲
Equity10/15€-49k€-62k▼
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€-70k€-83k▼
Amounts payable17/49€199k€350k▲
Amounts payable within one year42/48€198k€319k▲
Trade debts44€13k€71k▲
Suppliers440/4€13k€71k▲
Taxes, remuneration and social security45€19k€21k▲
Taxes450/3€2k-
Remuneration and social security454/9€18k€21k▲
Other amounts payable47/48€165k€227k▲
Accrued charges and deferred income492/3€1k€30k▲
Income statement Code20242025
Remuneration, social security and pensions62€39k€91k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€30k▲
Other operating charges640/8€638€3k▲
Gross operating margin9900€-9k€112k▲
Operating profit (loss)9901€-53k€-12k▲
Financial charges65/66B€161€749▲
Recurring financial charges65€161€749▲
Profit (loss) for the period before taxes9903€-53k€-13k▲
Profit (loss) for the period9904€-53k€-13k▲
Profit (loss) for the period to be appropriated9905€-53k€-13k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-70k€-83k▼
Profit (loss) brought forward from the previous period14P€-17k€-70k▼

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Remuneration, social security and pensions62-€24k€40k€39k€91k▲ 135%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€294€1k€4k€30k▲ 598%
Other operating charges640/8-€721€384€638€3k▲ 305%
Gross operating margin9900€-149€30k€2k€-9k€112k▲ 1,379%
Operating profit (loss)9901€-149€5k€-39k€-53k€-12k▲ 77.1%
Financial income75/76B-€0----
Recurring financial income75-€0----
Financial charges65/66B€20€299€159€161€749▲ 365%
Recurring financial charges65€20€299€159€161€749▲ 365%
Profit (loss) for the period before taxes9903€-168€5k€-40k€-53k€-13k▲ 75.7%
Profit (loss) for the period9904€-168€5k€-40k€-53k€-13k▲ 75.7%
Profit (loss) for the period to be appropriated9905€-168€5k€-40k€-53k€-13k▲ 75.7%
Line20212022202320242025Change
Assets
Total assets20/58€26k€50k€22k€150k€288k▲ 92.2%
Fixed assets21/28-€8k€7k€136k€141k▲ 3.6%
Intangible fixed assets21-€2k€1k€3k€8k▲ 166%
Tangible fixed assets22/27-€2k€1k€128k€127k▼ 0.3%
Plant, machinery and equipment23---€125k€123k▼ 0.9%
Furniture and vehicles24-€2k€1k€3k€4k▲ 26.3%
Financial fixed assets28-€4k€4k€5k€5k=
Current assets29/58€26k€42k€15k€14k€147k▲ 970%
Amounts receivable within one year40/41€25k€20k€14k€3k€105k▲ 3,414%
Trade receivables40-€17k€10k-€100k-
Other amounts receivable41€25k€3k€4k€3k€5k▲ 64.3%
Cash at bank and in hand54/58€872€22k€1k€6k€30k▲ 412%
Deferred charges and accrued income490/1---€5k€12k▲ 139%
Equity and liabilities
Total equity and liabilities10/49€26k€50k€22k€150k€288k▲ 92.2%
Equity10/15€26k€31k€-9k€-49k€-62k▼ 25.9%
Contributions10/11€6k€6k€6k€19k€19k=
Capital10€6k€6k€6k---
Issued capital100€19k€19k€19k---
Uncalled capital101€12k€12k€12k---
Reserves13€2k€2k€2k€2k€2k=
Non-distributable reserves130/1€2k€2k€2k---
Legal reserve130€2k€2k€2k---
Distributable reserves133---€2k€2k=
Profit (loss) carried forward14€18k€22k€-17k€-70k€-83k▼ 18.3%
Amounts payable17/49€284€20k€31k€199k€350k▲ 75.8%
Amounts payable within one year42/48€284€20k€31k€198k€319k▲ 61.6%
Trade debts44-€11k€19k€13k€71k▲ 440%
Suppliers440/4-€11k€19k€13k€71k▲ 440%
Taxes, remuneration and social security45-€9k€10k€19k€21k▲ 10.2%
Taxes450/3-€3k-€2k--
Remuneration and social security454/9-€6k€10k€18k€21k▲ 20.7%
Other amounts payable47/48€284€462€3k€165k€227k▲ 37.6%
Accrued charges and deferred income492/3---€1k€30k▲ 2,235%
Line20212022202320242025Change
Profit (loss) for the period9904€-168€5k€-40k€-53k€-13k▲ 75.7%
+ Depreciation and write-downs630-€294€1k€4k€30k▲ 598%
Operating cash flow (approximation)€-168€5k€-39k€-48k€18k▲ 137%
Investment in fixed assets (approximation)--€-330€-133k€-35k▲ 73.4%
Change in cash-€22k€-21k€5k€24k▲ 428%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
29-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial Weakest financial yearnet €-53k
Net result drops to €-53k, the lowest in the series; recovery starts the following year.
30-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
29-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
31-12
Financial Back to profitnet €5k
Net result €5k after 4 loss-making years.
30-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
16-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Liquidity times 33current ratio 231.47
Current ratio from 7.09 to 231.47; short-term debt falls from €4k to €115.
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
25-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2011
seat establishment The establishment unit on the map
Ground area
1,326 m²
Building footprint
436 m²
Volume, LiDAR
3,403 m³
2 parcels, Brussels, Flanders · tallest building 20.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Midiclinic
Maurice Lemonnierlaan 94, 1000 BrusselHuman health activities
since 20112.201.524.074
2 parcels
Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
23352F0271/00N000 Flanders 1,080 m² 1 · 184 m² 0.2 m
21809K0065/02H008 Brussels 246 m² 1 · 252 m² 20.1 m · 4 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 24,855 companies in sector 96220 we hold annual accounts for 1,439. 1,169 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded12-08-2011
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
96220Beauty care and other beauty treatments

Scores and ratios are computed by Checked and are not a credit decision.